Abstract:As a zoonotic disease that has already spread globally to several million human beings and possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID-19) appears practically impossible. There is a pressing need to improve our understanding of the immunology of this disease to contain the pandemic by developing vaccines and medicines for the prevention and treatment of patients. In this review, we aim to improve our understanding on the immune response and immunopathological changes in patients linked to deteriorating clinical conditions such as cytokine storm, acute respiratory distress syndrome, autopsy findings and changes in acute-phase reactants, and serum biochemistry in COVID-19. Similar to many other viral infections, asymptomatic disease is present in a significant but currently unknown fraction of the affected individuals. In the majority of the patients, a 1-week, self-limiting viral respiratory disease typically occurs, which ends with the development of neutralizing antiviral T cell and antibody immunity. The IgM-, IgA-, and IgG-type virus-specific antibodies levels are important measurements to predict population immunity against this disease and whether cross-reactivity with other coronaviruses is taking place. High viral load during the first infection and repeated exposure to virus especially in healthcare workers can be an important factor for severity of disease. It should be noted that many aspects of severe patients are unique to COVID-19 and are rarely observed in other respiratory viral infections, such as severe lymphopenia and eosinopenia, extensive pneumonia and lung tissue damage, a cytokine storm leading to acute respiratory distress syndrome, and multiorgan failure. Lymphopenia causes a defect in antiviral and immune regulatory immunity. At the same time, a cytokine storm starts with extensive activation of cytokine-secreting cells with innate and adaptive immune mechanisms both of which contribute to a poor prognosis. Elevated levels of acute-phase reactants and lymphopenia are early predictors of high disease severity. Prevention of development to severe disease, cytokine storm, acute respiratory distress syndrome, and novel approaches to prevent their development will be main routes for future research areas. As we learn to live amidst the virus, understanding the immunology of the disease can assist in containing the pandemic and in developing vaccines and medicines to prevent and treat individual patients.

Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Immune Response to SARS-CoV-2 and Mechanisms of Immunopathological Changes in COVID-19.

COVID-19: immunopathogenesis and Immunotherapeutics

SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19

Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses

SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines

Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics

Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection

COVID-19: Imbalanced Cell-Mediated Immune Response Drives to Immunopathology

SARS-CoV-2, Inflammatory Apoptosis, and Cytokine Storm Syndrome

SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets

COVID-19: from immune response to clinical intervention.

The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?

Insight into the Emerging Role of SARS-CoV-2 Nonstructural and Accessory Proteins in Modulation of Multiple Mechanisms of Host Innate Defense.

The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections

An Update on Innate Immune Responses during SARS-CoV-2 Infection

The trinity of COVID-19: immunity, inflammation and intervention

Humoral immune mechanisms involved in protective and pathological immunity during COVID-19

How does the Immunological System Change during the SARS-COV-2 Attack? A Clue for the New Immunotherapy Discovery